| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/02/2000 | CA2341309A1 Use of mcrp for delivery of materials into cells |
| 03/02/2000 | CA2341220A1 Spray on bandage and drug delivery system |
| 03/02/2000 | CA2340787A1 An anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
| 03/02/2000 | CA2340692A1 Immunogenic .beta.-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide |
| 03/02/2000 | CA2340649A1 Phosphoglycolipid and methods for its use |
| 03/02/2000 | CA2340595A1 Streptavidin mutants having secondary functional domains |
| 03/02/2000 | CA2338688A1 Oral mucoadhesive compositions containing gastrointestinal actives |
| 03/02/2000 | CA2253058A1 Therapeutic composition that produce and immune response |
| 03/01/2000 | EP0982348A1 Polymer composition and process for its manufacture |
| 03/01/2000 | EP0982317A1 Bivalent inhibitors of the proteasome |
| 03/01/2000 | EP0982035A1 Cyclosporin composition comprising an hydrophilic carrier |
| 03/01/2000 | EP0982025A1 Synthetic tear fluid |
| 03/01/2000 | EP0982022A2 Fragrance releasing non-volatile polymeric siloxanes |
| 03/01/2000 | EP0981969A1 Carotinoid compositions comprising a mixture of beta-carotene, lycopene and lutein |
| 03/01/2000 | EP0981748A1 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 03/01/2000 | EP0981649A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |
| 03/01/2000 | EP0981607A1 Modiified arginine deiminase |
| 03/01/2000 | EP0981548A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
| 03/01/2000 | EP0981381A2 POLYHYDROXYALKANOATES FOR $i(IN VIVO) APPLICATIONS |
| 03/01/2000 | EP0981377A1 Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof |
| 03/01/2000 | EP0981376A1 Targeted therapeutic delivery of vitamin d compounds |
| 03/01/2000 | EP0981375A1 Pharmaceutical compositions containing plasma protein |
| 03/01/2000 | EP0981374A2 Sustained-release delayed gels |
| 03/01/2000 | EP0981373A1 Biofunctional polymers prepared in supercritical fluid |
| 03/01/2000 | EP0981370A1 A method of preservation of vaccines with polybiguanide |
| 03/01/2000 | EP0981345A1 Methods and compositions for the protection of mitochondria |
| 03/01/2000 | EP0981340A1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound |
| 03/01/2000 | EP0981334A1 Swallow tablet comprising paracetamol |
| 03/01/2000 | EP0981333A1 Novel acoustically active drug delivery systems |
| 03/01/2000 | EP0981332A1 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation |
| 03/01/2000 | EP0981328A1 Emulsion vehicle for poorly soluble drugs |
| 03/01/2000 | EP0885060A4 Solid and semi-solid hydrocarbon gels and uses thereof |
| 03/01/2000 | CN1246058A Oil-free pharmaceutical compositions containing cyclosporin A |
| 03/01/2000 | CN1246057A Oral cyclosporin formulations |
| 03/01/2000 | CN1246055A Freeze-dried composition containing glycosphingolipid and process for producing the same |
| 03/01/2000 | CN1246054A Use of green porphyrins for manufacture of medicament for treatment of secondary cataracts |
| 03/01/2000 | CN1246053A Plasticizer and patch containing plasticizer |
| 03/01/2000 | CN1049820C Etoposide preparations |
| 03/01/2000 | CN1049817C Method for preparation of percutaneously absorbable drug composition |
| 03/01/2000 | CA2246773A1 Topical antibiotic composition providing optimal moisture environment for rapid wound healing that reduces skin contraction |
| 02/29/2000 | US6031043 Topical composition comprising a hydrophilic gelling agent of polyester sulphone type |
| 02/29/2000 | US6031017 Photocured cross-linked-hyaluronic acid gel and method of preparation thereof |
| 02/29/2000 | US6031007 A homogenous dental emulsion or microemulsion of local anesthetic in oil form, a surfactant having thermoreversible gelling properties, i.e. thickening when contacting mucous membranes, and water; pathological periodontal pockets; scale |
| 02/29/2000 | US6030998 Using a parenteral solution of amiodarone free of any tween surfactant and having a ph of 3.5-4.0 at a concentration of about 10-50 mg/ml; side effect reduction; storage stability; nonsettling |
| 02/29/2000 | US6030988 Immediate release pH-independent solid dosage form of cisapride |
| 02/29/2000 | US6030958 Combining in aqueous solution, polyanionic polysaccharide selected from carboxymethylcellulose and carboxymethylamylose and carbodimide in acidic conditions |
| 02/29/2000 | US6030954 To block expression of a gene or genes in the cell |
| 02/29/2000 | US6030953 For preventing and treating anal leakage of oil in a patient |
| 02/29/2000 | US6030948 Hair regeneration compositions for treatment of alopecia and methods of application related thereto |
| 02/29/2000 | US6030945 Apo-2 ligand |
| 02/29/2000 | US6030941 Polymer composition for delivering substances in living organisms |
| 02/29/2000 | US6030673 Starch-bound cellular matrix formed by gelatinizing a starch based binder with water and hardening by evaporating water to form inner foam and outer skin and coating with specific natural or synthetic biodegradable materials |
| 02/29/2000 | US6030645 Free-flowing dry particles |
| 02/29/2000 | US6030636 Calcium sulfate controlled release matrix |
| 02/29/2000 | US6030622 Herbal extract composition and method with immune-boosting capability |
| 02/29/2000 | US6030613 Receptor specific transepithelial transport of therapeutics |
| 02/29/2000 | US6030602 Peptide conjugates for transfecting cells |
| 02/29/2000 | CA2093928C Monoclonal antibodies for detection and treatment of cancer |
| 02/29/2000 | CA2046739C Coated solid medicament form having releasability in large intestine |
| 02/28/2000 | CA2281442A1 Use of a cationic polymer for the preparation of a complex with nucleic acid and related compositions |
| 02/24/2000 | WO2000009730A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 02/24/2000 | WO2000009675A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | WO2000009652A2 Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof |
| 02/24/2000 | WO2000009566A1 Method for producing ultra-pure alginates |
| 02/24/2000 | WO2000009179A2 Methods, instruments and materials for chondrocyte cell transplantation |
| 02/24/2000 | WO2000009166A2 Phosphorylated polymers and conjugates thereof |
| 02/24/2000 | WO2000009165A1 Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| 02/24/2000 | WO2000009164A1 Antibodies for use in targeted and temporary treatment of humans and animals |
| 02/24/2000 | WO2000009163A1 Conjugated linoleic acid alkyl esters in feedstuffs and food |
| 02/24/2000 | WO2000009158A1 Assay for assembly of herpes simplex virus capsid |
| 02/24/2000 | WO2000009155A1 Methods and compositions for preventing anti-gal production in xenograft recipients |
| 02/24/2000 | WO2000009146A1 Treatment of disease states |
| 02/24/2000 | WO2000009143A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 02/24/2000 | WO2000009134A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women |
| 02/24/2000 | WO2000009123A1 Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 02/24/2000 | WO2000009122A1 Pharmaceutical compositions containing lipase inhibitors |
| 02/24/2000 | WO2000009117A1 Nimesulide containing topical pharmaceutical compositions |
| 02/24/2000 | WO2000009097A2 Pharmaceutical composition with antitumor activity on the basis of carboplatin |
| 02/24/2000 | WO2000009096A1 Injectable formulations of nanoparticulate naproxen |
| 02/24/2000 | WO2000009093A1 Microemulsions as solid dosage forms for oral administration |
| 02/24/2000 | WO2000009092A1 Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles |
| 02/24/2000 | WO2000009090A1 Orally disintegrable tablet forming a viscous slurry |
| 02/24/2000 | WO2000009089A1 Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient |
| 02/24/2000 | WO2000009087A1 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 02/24/2000 | WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 02/24/2000 | WO2000009084A2 Biodegradable microparticles gel composition |
| 02/24/2000 | WO2000009073A2 Blood-brain barrier therapeutics |
| 02/24/2000 | WO1999065461A3 Cationic amphiphile micellar complexes |
| 02/24/2000 | WO1999064050A8 Novel potassium channel drugs and their uses |
| 02/24/2000 | WO1999059638A3 Compositions and methods for the delivery of nucleic acid molecules |
| 02/24/2000 | WO1999045788A8 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 02/24/2000 | WO1999045127A3 Enhanced prodrug activation |
| 02/24/2000 | DE19837234A1 Polymerzusammensetzung und Verfahren zu deren Herstellung The polymer composition and process for their preparation |
| 02/24/2000 | DE19835239A1 Schäumende Ölzubereitung und deren Verwendung Foaming oil preparation and their use |
| 02/24/2000 | DE19834006A1 Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen Estradiolhaltiges patch for transdermal administration of hormones |
| 02/24/2000 | CA2340682A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | CA2340418A1 Blood-brain barrier therapeutics |
| 02/24/2000 | CA2340257A1 Treatment of disease states |
| 02/24/2000 | CA2340177A1 Biodegradable microparticles gel composition |
| 02/24/2000 | CA2340116A1 Antibodies for use in targeted and temporary treatment of humans and animals |